Qutenza® (capsaicin) 8% patch

Patient Site | Full Prescribing Information | Register for Updates | Join Find A Doctor
Tell A Colleague | Print |
Physician Resources

Register for Qutenza® Updates

To be notified about important clinical and research developments regarding Qutenza®, simply fill out the form below.

*Required fields


Prefix:

First Name:  *
Enter first name

Last Name:  *
Enter last name

Affiliation:

E-mail Address:  *
Enter valid e-mail

Street Address:

Street Address 2:

City:

ZIP Code:

Telephone:

Which of the following best describes you?

I am a physician    My specialty is:

I am a nurse    My specialty is:

I am a healthcare professional other than a physician or nurse    My specialty is:

 I agree to receive future updates.

  I have read, understood, and agreed to the NeurogesX Privacy Policy.* I understand that by submitting this request, I am allowing NeurogesX or its contractors to contact me.
You must agree to NeurogesX Privacy Policy

NeurogesX and companies working with NeurogesX will not share the information you provide with any third parties. To remove yourself from future contact with NeurogesX, unsubscribe. To read our terms and conditions, click here.


   


Request Qutenza® TRAINING
Call 877-900-6479

Get Info

Order Qutenza®

Qutenza®

Support For Your Practice

Connect Now

Indication: Qutenza® (capsaicin) 8% patch is indicated for the management of neuropathic pain associated with postherpetic neuralgia.

IMPORTANT SAFETY INFORMATION

Only physicians or healthcare professionals under the close supervision of a physician are to administer Qutenza®.

Contraindications: None.

Warnings and Precautions:

  • Do not use on face or scalp.
  • Aerosolization of capsaicin can occur and inhalation may result in coughing or sneezing.
  • If skin not intended to be treated comes into contact with Qutenza®, clean area using Cleansing Gel.
  • Patients may experience substantial procedural pain. Prepare to treat pain with local cooling (such as a cold pack) and/or appropriate analgesic medication.
  • Transient increases in blood pressure may occur during and shortly after the Qutenza® treatment. In clinical trials, blood pressure changes were associated with treatment-related increases in pain. Monitor blood pressure and provide adequate support for treatment-related pain. Patients with unstable or poorly controlled hypertension or a recent history of cardiovascular or cerebrovascular events may be at an increased risk of adverse cardiovascular effects. Consider these factors prior to initiating Qutenza® treatment.

Adverse Reactions: In clinical trials, serious adverse reactions included application-associated pain and increase in blood pressure. The most common adverse reactions (≥ 5% and greater than control) were application-site erythema, application-site pain, application-site pruritus, and application-site papules.

For additional information, please click here for full Prescribing Information.

Patient Site| Contact Us|Site Map|Privacy Policy |Terms of Use|Full Prescribing Information| NeurogesX.com|Unsubscribe|Find A Doctor Opt-Out
NeurogesX - Changing the course of pain

©NeurogesX, Inc. 2010. All Rights Reserved. ®marks owned by NeurogesX, Inc. Q2010032-13 110453